噬菌体疗法改善实验性金黄色葡萄球菌呼吸机相关性肺炎结局
研究在大鼠耐甲氧西林金黄色葡萄球菌呼吸机相关性肺炎模型中,比较静脉替考拉宁、四株噬菌体鸡尾酒及二者联合的疗效。主要终点为第4天生存率。噬菌体与替考拉宁均将生存率从0%提高至58%和50%(P < 0.005),联合治疗未进一步改善结局(45%生存率)。
要点
- 噬菌体疗法与替考拉宁在改善生存和降低肺内细菌负荷方面效果相当。
- 噬菌体与抗生素联合未进一步提高生存率或额外获益。
- 动物生存与肺组织细菌负荷降低及组织病理学改善相关。
核心结论
- 静脉噬菌体疗法在改善大鼠耐甲氧西林金黄色葡萄球菌呼吸机相关性肺炎生存率和降低肺内细菌负荷方面与替考拉宁同样有效。
- 噬菌体与替考拉宁联合治疗未进一步改善结局。
研究设计与样本
- 随机、盲法、对照的实验研究。
- 比较静脉替考拉宁(3 mg/kg,n = 12)、四株噬菌体鸡尾酒(2-3 × 10^9 空斑形成单位/ml,n = 12)及二者联合(n = 11)。
- 在诱导肺炎后2、12、24小时给药,之后每日一次持续4天。
主要发现
- 噬菌体组和替考拉宁组生存率分别从0%提高至58%和50%(P < 0.005)。
- 联合治疗组生存率为45%,未进一步改善结局。
- 存活动物肺组织细菌负荷为1.2 × 10^6 cfu/g,非存活动物为1.2 × 10^9 cfu/g(P < 0.0001)。
- 治疗期间噬菌体在肺内增殖。
- 所有治疗组IL-1β在治疗过程中均升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Infections caused by multidrug-resistant bacteria are a major clinical challenge. Phage therapy is a promising alternative antibacterial strategy.Objectives: To evaluate the efficacy of intravenous phage therapy for the treatment of ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus in rats.Methods: In a randomized, blinded, controlled experimental study, we compared intravenous teicoplanin (3 mg/kg, n = 12), a cocktail of four phages (2-3 × 109 plaque-forming units/ml of 2003, 2002, 3A, and K; n = 12), and a combination of both (n = 11) given 2, 12, and 24 hours after induction of pneumonia, and then once daily for 4 days. The primary outcome was survival at Day 4. Secondary outcomes were bacterial and phage densities in lungs and spleen, histopathological scoring of infection within the lungs, and inflammatory biomarkers in blood.Measurements and Main Results: Treatment with either phages or teicoplanin increased survival from 0% to 58% and 50%, respectively (P < 0.005). The combination of phages and antibiotics did not further improve outcomes (45% survival). Animal survival correlated with reduced bacterial burdens in the lung (1.2 × 106 cfu/g of tissue for survivors vs. 1.2 × 109 cfu/g for nonsurviving animals; P < 0.0001), as well as improved histopathological outcomes. Phage multiplication within the lung occurred during treatment. IL-1β increased in all treatment groups over the course of therapy.Conclusions: Phage therapy was as effective as teicoplanin in improving survival and decreasing bacterial load within the lungs of rats infected with methicillin-resistant S. aureus. Combining antibiotics with phage therapy did not further improve outcomes.
引用
- Prazak J, Iten M, Cameron DR, et al. Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia. Am J Respir Crit Care Med. 2019. PMID: 31260638. doi:10.1164/rccm.201812-2372OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。